Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Short positions are closing and institutional holdings now up to 74 percent
I can't remember her pumping the stock specifically, but she was a Bozo Berman (ball) plate licker for sure. we can all get excited about a stock we own, I only remember her for sure loving the diabetes biz and claiming Bozo Berman was going to beat J&J.
which moniker do you think she was here, I Non for a while but not really sure.
Institutions buying heavy, institutional ownership jumped from 53% to 75% in the last few weeks.
Regardless of Nestle or retail sales, if there is going to be a monster payoff here the nausea trial for chemo patients will be it.
TAUG certainly has the ability to be a winner based on retail for sure, maybe even have a $100 million or more market cap from it. But the elephant is the pharma.
Nestle bought Skinny Cow when it was a micro cap and turned that into a very profitable brand
Nestle has been on the periphery of TAUG's products since the rollout of the gum. Matt had nothing to do with Nestle approving its biggest ice cream distributor from selling the product when it first launched.
I am not sure if he had anything to do with Nestle's pharma division sponsoring and funding most of the liver toxicity study. I doubt it as that would have been a decision from the pharma side.
CBD is very big in the US and EU. I think TAUG already has inroads with Walmart, CVS, Target, Amazon ect, they are just not selling CBD yet. I hope that other distribution channels are open through this.
Fun fact, a previous board member of TAUG who loved the products had to resign when he became a Board member of Draft Kings. They did not want any of their Directors on micro - cap boards.
I doubt the 29th largest company in the world would let an executive as high the chain up as Matt willy-nilly go on the Board of Advisors. Of course, there will be some jealous haters that have not invested a penny in TAUG and have been wrong about many things for years try to babble nonsense.
Board seems quite lately. I think 2022 will be VTGN's big breakout
Agreed, she loaded up after the reverse splits wiped her original holdings out. I am not sure about her, maybe she believed the Berman Bullcrap
Think the trial judge is friends with the other judges in that court Bozo Berman insulted on this board during the J&J lawsuit?
Ha.. Well I suppose this jury is going to hear an earful, and be highly entertained. If Bozo doesn't plea
Hey, my crystal ball shattered long ago but if you need some help reading the tea leaves, well, here ya go.
1. Nestles originally approved its largest Hagen das Distributor in the US to sell TauriGum, then Coumo put those stupid rules in New York which killed the launch.
2. Next Nestles, which didn't have any CBD products started selling CBD products.
3. Next Nestles sponsored and funded most of the liver toxicity study that Taug is in for the nausea drug trial, which is a $7 billion dollar annual industry. nestles is a huge pharma player.
4. Taug has an investment and long relationship with the folks at Aegea, maybe Nestles has an interest in that as well.
Nestles bought into Skinny Cow when it was a small over the counter stock. (losing money)
Gotta love the Rolodex!!
Cant argue with you there, the malpractice, lawsuit and a terrible trust in a convertible note guy caused that.
But, essentially, this company started over from scratch and has a chance to be worth quite a bit.
The fact is now that there is cash flow, decent equity holdings and the potential retail and pharma biz this currently has alot more going for it than a normal low priced spec stock.
Time will tell
I have a bunch of Clown wigs I could send him.. Hey, going way back, Barbara Asbell use to post to me that Bozo Berman had to use disguises to fly to South Korea because J&J secret squirrel guys were following him..
Maybe one of the disguises was a cane or wheelchair
LMFAO.. Nestles approved Tauriga's products to be sold by its largest Hagen das distributor, that had nothing to do with M&A, at the time Nestles did not have any CBD products.
Nestles sponsored and funded most of the cohort for the safety trial for liver toxicity. Nestles has a huge pharma division and now sell retail CBD products.
Nice try, you think the #7 guy at the 29th largest market cap company in the world is going to just jump on any Board, then you don't understand corporations.
One of Serendiity's owners was the founder of Skinny Cow, that was a pink sheet company that Nestles bought and grew the brand.
Keep trying...
Also nestles could be very interested in Aegea's Covid test for the EU. That is just speculation on my part but if this test is better than other PCR tests it is a game changer. He could have joined the Board anytime, if I was thinking like you, but he joined shortly after the Aegea announcement
LMFAO keep trying though
Thanks, just read it.. Wow it is a month away...maybe the trial is a week or two long at best.
Not many people realize that Nestles has a Huge pharma division!
Today Quest announced it was going to utilize Biocept's liquid biopsy test. As they do Covid testing I think the timing is quite odd because they could have offered that long before this Covid test of Aegea's is validated.
Now there are 3 huge companies directly or indirectly involved with TAUG and BIOC, Nestles, Thermal Fisher and Quest.
No blues here... I bet Bozo Berman wishes he didn't screw things up with TAUG. LMFAO..
https://www.globenewswire.com/news-release/2021/12/01/2344073/0/en/Tauriga-Sciences-Inc-Appoints-Matthew-A-Shaw-as-Member-of-Its-Corporate-Advisory-Board.html
Johnny Johnny why so pessimistic?
Good points as always.
You could be right. And now I can see everyone getting in a tizzy with the latest Covid mutation. That caused delays in the past.
Well, maybe berman will be 80 before his big day in court
Well, out of the blue another asset of TAUG raises its hand. The Aegea test now has been validated and it can identify different mutations.
If I understand that correctly, Aegea can tell the different mutations of corona through PCR tests using traditional PCR equipment.
Right now, more expensive and complicated tests are being done on a few samples compared to the number of monthly tests through sequencing. There are over 350,000 tests in the US alone right now.
Has anyone listened to the PFE CEO, he thinks if it is needed within weeks, PFE can recode the RNA vaccines to be effective against this new variant if the previous vaccines are not efficacious.
What would a test kit be worth that could identify a specific mutation on every PCR test? My bet is quite a bit?
In fact, I would not be surprised if Aegea Biotechnologies becomes worth 100's of millions of dollars. If so TAug's investment in Aegea could be valued more than the current market cap of TAUG.
I do not like Biocept or its CEO Nall, I think he is a dirtbag penny stock scammer, but since BIOC holds the licensing rights to Aegea's test it seems like a no-brainer to buy. They were barely doing $2 mil in annual cancer screenings and now book about $15 million a quarter in Covid testing. Out of the blue, Quest is now going to start using Biocept's cancer screening tests in January 2023. Quest does quite a of.....COVID Testing. Biocept is located right next to Thermal Fisher, a worldwide top 70 company in market cap. new EUA rules require the manufacturer to be able to produce 500,000 tests a week. Perhaps Aegea is grandfathered in under the old rules. In any event, a very big manufacturing partner is needed.
Why would Nall state that they were not commercializing the test at this time? Very Odd since on the same day Aegea stated they were in talks with the FDA.
"US public health labs sequencing 4 times as many coronavirus specimens now compared to a year ago"
From CNN's Jacqueline Howard
As full disclosure, this is not investment advice to buy BIOC. That company burned me pretty well earlier. I bought calls because I think there is upside because the stock price is low, and it minimizes risk. However, they could expire worthless. It doesn't make sense to validate a test that is better than the other ones on the market and not get it into production immediately.
As far as TAUG the Aegea investment is interesting.
Doesn't look like any little companies are going to be able to get EUA's anymore. New rules require production of 500,000 units a week. so any of these covid test pumps will have to go through a large company from now on
If there is a big payoff it is going to come from the Pharma side. Once the patent is issued, hopefully, that will become a positive catalyst. Figure a trial itself to be at least 24 months.
IMO a $15 million dollar valuation is low. I remember when VTGN went down to a $37 million dollar valuation and one good readout pushed it to a $550,000,000 valuation. These stocks are not for the feint of heart. Luckily you can chew their CBD gum to relieve all the stress the stock price brings.
Attorneys earning their pay! I doubt that motion effects trial date
How are they still keeping the lights on?
Might even be a cross marketing potential.
It certainly has a twist of irony to it.
This was a pretty good find by loanranger as to the Bozo Berman's alias predictions as Pluto..
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=154941657
Doesn't look like he was right about much!
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166920378
Looks like they cannot put CBD products on Amazon, but they have quite a variety.
Aegea Technologies has updated its website, now includes COVID and PCR testing
https://www.aegeabiotech.com
Let's look at how accurate Bozo Berman was;
TAUG consultant John Cesario told a person who takes large positions in stocks that TAUG's new Covid-19 test kit will be approved by the FDA next week
I guess he was right, $2,000,000 was a large position, but he was wrong about my having any FDA knowledge. Furthermore, at the time of that post, nobody was going for FDA clearance as that would have taken a year or more. Companies were trying to get EUA's and all that was required was validation by a CLIA lab, which Biocept was. So no interaction with the FDA was needed.
Very good find. However I never told anyone that a test was going to be FDA approved. So Bozo Berman was full of crap, as usual. In fact, I didn’t invest in Aegea although I was close. A friend did though, $2 mil
I am not sure where Aegea stands with getting FDA clearance, but EUA is guaranteed approval is guaranteed provided they get a partner that can produce 500,000 tests a month.
Sure looks looks this product will see the light of day, unlike Bozo Bermans
Looks like one of those share issuance and convertible notes might have resulted in Seth using $350,000 to strike GOLD. For instance, as far as I know TAUG is the only public entity that has a stake in Aegea (that may have changed in the past 6 months, I am not sure).
If Aegea's test takes off TAUG's investment in Aegea could be worth as much as the TAUG's current market cap!
Aegea seems to have a test that not only is extremely accurate in diagnosing COVID, but can tell the difference between the flu and different variants.
Currently, there are 350,000 DAILY tests alone in the U.S.
Does anyone think Quest or Thermal Fisher will want this test? To get an EUA the FDA now wants a company to be able to be capable of producing 500,000 tests a week. Aegea does not have that capability. They need a big partner.
Also, previously, Aegea told me that this type of test gets a $400 dollar reimbursement as opposed to a $100 reimbursement. I am not sure if that still holds, given the emphasis on home kits, but this test will certainly command more than a normal lab test.
Seth never gets any credit for the good moves he has made, and IMO he has made more good moves than bad trying to put Tauriga in a position to be very successful! This Company started from scratch 2 1/2 years ago.
Aegea could very well become a 1/2 billion dollar company overnight.
Just in the US over 10 million tests are done a month, if Aegea, through a large partner captures just 20% of that business and sells the test for $25 they could generate $50 million dollars a month in revenue.
Aegea also owns multiple switch blocker patents for disease testing. many are very valuable and are just sitting dormant because they have not been discovered. One test, is very highly rated by doctors and hospitals, but unfortunately, Biocept has not been able to commercialize it properly.
The liquid biopsy market is huge! Aegea will get quite a bit of attention in the next few months especially with new variants in the news. That has to draw interest to the other IP's they have. Aegea's CEO is in his 70's so I would think a buyout is a consideration over the next couple years..
https://www.medtechdive.com/news/illumina-inks-8b-grail-buyout-for-liquid-biopsy-market-investors-are-not/585584/
https://www.genomeweb.com/business-news/agilent-technologies-acquire-liquid-biopsy-firm-resolution-bioscience-695m#.YaIlUtDMLZs
Anyway, what is your analysis of this current turn of events?
Interesting news, TUAG is a public company that owns a small percentage of Aegea. Biocept has the first right to negotiate a licensing deal.
I think Aegea is about to become huge value, especially given the news. Both these public companies should benefit
Opps. For an EUA to be issued, a company needs to affirm it can produce 500,000 tests a week. Not 500 million.
Bozo Berman must have been channeling me to exagerate!
https://www.fda.gov/media/135659/download
Odds are he will never stipulate to that. By the way, isn't it funny how things work out. All this Covid test hype by Bozo Berman and Bozo Berman laughing at TAUG for investing in a Covid test that he claimed was hype.
Bozo Berman's test was BS and now the test that TAUG has invested in through AEGEA Technologies has now been validated and not only does it detect Covid-19, but the validation claims that the test can differentiate between the flu and can distinguish different variants.
To my knowledge, no other test assay in the world can do that whether the test is PCR, Blood, Spit, urine or crap.
Funny how things work out. Guess I was right advocating that Bozo Berman and DECN not reverse merge into TAUG which was only to cover up Bozo Berman's and DECN's financial malfeasance.
I think Aegea, if the validation is true, is not a $10 mil valuation anymore. I think it is on the way to being $100's of million dollars valuation if not $1 billion.
I wonder what will drive Bozo Berman more crazy, not being able to post nonsense or the success of a real company developing a Covid test.
It gets even better, to get an EUA under the new rules, a company needs to affirm to the FDA that it can produce 500 million tests a month. Aegea cannot do that, Biocept cannot do that, so they will need to partner with a Quest, Thermal Fisher type company.
I don't think there are any convertibles at deep discounts left, and it looks like TAUG stock investments are doing well, so I think they have cash available.
VTGN is up and trading in the low 2's with a Phase 3 readout on the first SAD drug that the FDA has fast tracked and given needed status to. VTGN now has massive institutional ownership and analysts are calling for $9.00 just on that one drug, which isn't there biggest. VTGN went from 0 institutions owning it to some of the biggest, I believe it is over 55% institutionally owned. Including by Franklin Templeton. Funny how Seth's rolodex includes the Head of Global at Franklin.
AXIM.. That stock is up double and could easily double again. The drug works and had a snafu on paperwork submitted to FDA. Keep an eye on that one.
GOEV (W) Looks like things are heating up there finally. They have received nearly $500 million bucks from Arkansas and appear to have over $1 billion in orders for its electric pickup.
Aegea will get interesting because of the latest news, and we are in flu season and new variants.
Serendipity Brands is about to launch a massive advertising campaign with Selena Gomez and I was told that there is discussions with Nesltes about doing 3 drink flavors. They are also launching other products.
While the Serendipity restaurants are not part of the Serendipity Brands they will promote ice cream for sure. NY location, where Presidents and famous stars have gone is remodeled. Miami has opened, and 8 other locations are being built, including inside Disney. The Walburg's have also signed an agreement to put 6 locations up.
GoPuff is a huge partner in Serendipity Brands. They also deliver alcohol in the States where it is allowed. Taug's products could fit in nicely there. I don't think many people at GoPuff are over 35 years old so maybe these products will interest them.
But like I have said repeatedly, the nausea drug trial for chemo patients is the biggest driver for me. I doubt much will happen till the patent is issued, besides the ongoing safety cohort.
If a company like BNOEF can retain 40% of its ownership in its drug through a partnership with MERC I can't see why Tauriga cannot enter into an arrangement like that with a Pharma player. The nausea market is a $7 billion plus annual market and the trial from soup to nuts will be under $80,000,000 That is a bargain as blockbuster drugs average over $1.5 billion dollars on average.
Can you imagine the outrageous PR's Bozo Berman would be putting out with this new Covid variant/with HIV.
I wonder if he is still writing PR's for fun..
The Aegea announcement is very interesting and a long time coming. This is one of TAUG's investments in a private company, the other being Serendipity. I have no investment in Aegea but do have one in Serendipity.
If Aegea test is validated as the Aegea and Biocept press releases indicate, then Aegea could very well become a very substantial investment for Tauriga.
I believe the original valuation for Aegea was around $10 million dollars. According to what Aegea told me when I was looking at investing in that company a test that can distinguish the difference between the flu and Covid commands a 4 - time reimbursement fee to the lab. A typical reimbursement for a COVID-19 lab test is about $105 per test. According to Aegea this test will get a $400 reimbursement.
Biocept shares one of Aegea's patents for PCR cancer pre screenings. Biocept jumped into Covid testing and went from virtually no sales to $17 mil a quarter.
A test that could distinguish the difference between the flu would be very valuable, take nursing homes and senior living centers as examples. Testing will not go away anytime soon, once PFE and Merc's Covid drugs are approved one would need a positive test to qualify for a prescription. The US has already ordered over $2 billion dollars of PFE's drug.
Go to a CVS and ask for a Delta variant test, they will tell you it cannot be done. If the Aegea test could differentiate between different strains, it could be a billion-dollar company.
Imagine what a company like Quest could do with this test. If Quest did 500,000 tests a month with a reimbursement of just $100 that would be $50 million dollars in revenue a month. At $200 a test it would be $100 million dollars a month. While those seem like pie in the sky projections, currently the US is processing over 350,000 tests a day, or almost 11 million tests a month. That is just in the US. Testing has a global market and Quest has huge contracts with large pharmacies and hospitals.
Emergency Use Authorizations are still being given out for Covid tests, but small companies will not be granted an EUA anymore. However, if a Company is able to manufacture 500,000 tests a week, they would get an EUA combined with the test results Aegea has produced. So they need a big partner or they have to go through the year long process of getting its test FDA cleared.
Just a little food for thought,it sure will be interesting to see how this plays out.
As far as Serendipity Ice Cream, I think things are looking encouraging there as well. Selena Gomez and GoPuff are also now investors like TAUG. GoPuff recently did a capital raise at an $11 Billion dollar valuation.
I hope GoPuff will look at distributing the gums and gummies.
Obviously, the core business is the CBD and other lines, and the huge value driver to shareholders is the Pharma trial for chemotherapy induced nausea, but these are some interesting tidbits.
This is not investment advice but just some interesting facts. I am still very long stock, but as I previously posted the PPS has been a downer the last 6 months.
Taug's stock holdings are interesting as well, VTGN AMIM and GOEVW all are looking good currently, VTGN should have a readout on its Phase 3 social anxiety drug in 2022. That is a multibillion dollar annual market. Most people should remember that VTGN had some dark days, it wasn't long ago that they did not have much cash and had a $40 million market cap. Now it has $100 mil in the bank and a $400 million dollar market cap. If TAUG's drug trial for nausea gets some traction this will be a very intersting story.
No I didn't see the transcript, but it wouldn't surprise me at all. I have bantered back and forth with him on multiple boards since 2015. So I think he will try to fight it unless the Govt reduces the terms they want.
Funny how this guy made a living on screwing investors for 30 plus years but would jump all over someone for a spelling mistake on a message board.
Out of all the outrageous shit he did, the Cabal / hacking nonsense wins the prize. Imagine how stupid `people were to believe that nonsense even when I showed them proof of the original PowerPoint. Then to get his groupies to sign a letter to the Internal Investigator head of the SEC is hilarious.